• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

出生队列和日历时期对卵巢癌发病率全球趋势的影响。

The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.

机构信息

Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.

Royal Marsden Hospital, London, United Kingdom.

出版信息

Int J Cancer. 2020 Feb 1;146(3):749-758. doi: 10.1002/ijc.32322. Epub 2019 Apr 30.

DOI:10.1002/ijc.32322
PMID:30968402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6786921/
Abstract

Ovarian cancer is the eighth most common cancer in women worldwide and incidence rates vary markedly by world region. Our study provides a comprehensive overview of ovarian cancer incidence trends globally, examining the influence of birth cohort and period of diagnosis on changing risk. We presented current patterns and trends of ovarian cancer incidence until 2012 using data from successive volumes of Cancer Incidence in Five Contents. The incidence of ovarian cancer is highest in northern and eastern European countries and in northern America. Declining trends were observed in most countries with the exception of a few central and eastern Asian countries. Marked declines were seen in Europe and North America for women aged 50-74 where rates have declined up to 2.4% (95% CI: -3.9, -0.9) annually in Denmark (DNK) over the last decade. Additionally, declines in the incidence rate ratio (IRR) were observed for generations born after the 1930s, with an additional strong period effect seen around 2000 in United States and DNK. In contrast, IRRs increased among younger generations born after the 1950s in Japan and Belarus. Overall, the favorable trends in ovarian cancer incidence is likely due to the increase use of oral contraceptive pills, and changes in the prevalence of other reproductive risk and protective factors for ovarian cancer over the years studied. Changes in disease classifications and cancer registry practices may also partially contribute to the variation in ovarian cancer incidence rates. Thus, continuous cancer surveillance is essential to detect the shifting patterns of ovarian cancer.

摘要

卵巢癌是全世界第八大常见女性癌症,其发病率在世界各地区差异显著。我们的研究提供了全球卵巢癌发病率趋势的综合概述,研究了出生队列和诊断时期对风险变化的影响。我们使用来自《五大洲癌症发病率》连续卷的数据,展示了截至 2012 年卵巢癌发病率的当前模式和趋势。卵巢癌发病率在北欧和东欧国家以及北美最高。除了少数中亚和东亚国家外,大多数国家的发病率呈下降趋势。在欧洲和北美,50-74 岁年龄段的妇女的发病率显著下降,丹麦在过去十年中,该年龄段的发病率每年下降 2.4%(95%CI:-3.9,-0.9)。此外,在 2000 年前后,美国和丹麦还观察到出生于 20 世纪 30 年代以后的几代人的发病率比(IRR)下降,且存在强烈的时期效应。相比之下,在日本和白俄罗斯,出生于 20 世纪 50 年代以后的年轻几代人的 IRR 有所增加。总体而言,卵巢癌发病率的有利趋势可能归因于口服避孕药的广泛使用,以及多年来其他生殖风险和保护因素对卵巢癌的流行情况的改变。疾病分类和癌症登记处做法的变化也可能部分导致卵巢癌发病率的差异。因此,持续的癌症监测对于发现卵巢癌模式的变化至关重要。

相似文献

1
The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.出生队列和日历时期对卵巢癌发病率全球趋势的影响。
Int J Cancer. 2020 Feb 1;146(3):749-758. doi: 10.1002/ijc.32322. Epub 2019 Apr 30.
2
Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.全球女性生殖系统癌症终生发病概率的差异:关于口服避孕药使用效果的最佳情况、最差情况及可能情况假设的影响
Contraception. 1992 Feb;45(2):93-104. doi: 10.1016/0010-7824(92)90043-s.
3
Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis.全球卵巢癌发病率的模式和趋势:年龄、时期和出生队列分析。
BMC Cancer. 2019 Oct 22;19(1):984. doi: 10.1186/s12885-019-6139-6.
4
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.欧洲的卵巢癌:1953 - 2000年28个国家发病率和死亡率的横断面趋势
Int J Cancer. 2005 Mar 1;113(6):977-90. doi: 10.1002/ijc.20649.
5
Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.英格兰和威尔士乳腺癌、卵巢癌及子宫内膜癌的发病率和死亡率近期趋势及其与生育变化和口服避孕药使用的关系。
Br J Cancer. 1995 Aug;72(2):485-92. doi: 10.1038/bjc.1995.360.
6
The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.口服避孕药和生育状况对55岁以下女性卵巢癌发病趋势的影响。
Br J Obstet Gynaecol. 1989 Jul;96(7):783-8. doi: 10.1111/j.1471-0528.1989.tb03316.x.
7
Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future.美国白人和澳大利亚女性激素使用情况及卵巢癌发病率趋势:对未来的启示。
Cancer Causes Control. 2017 May;28(5):365-370. doi: 10.1007/s10552-017-0868-0. Epub 2017 Feb 23.
8
Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.美国女性卵巢癌发病率下降与生育情况及口服避孕药使用的关系。
Epidemiology. 2000 Mar;11(2):102-5. doi: 10.1097/00001648-200003000-00004.
9
Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.荷兰的卵巢癌发病率(1989 - 1991年)及死亡率(1954 - 1993年)。
Obstet Gynecol. 1996 Sep;88(3):387-93. doi: 10.1016/0029-7844(96)00198-6.
10
Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.欧洲子宫内膜癌发病率趋势:潜在决定因素及预防前景
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1132-42. doi: 10.1158/1055-9965.EPI-04-0871.

引用本文的文献

1
Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study.1990年至2021年45岁及以上女性卵巢癌的全球、区域和国家负担以及2050年预测:基于2021年全球疾病负担研究的系统分析
J Cancer Res Clin Oncol. 2025 Aug 2;151(8):225. doi: 10.1007/s00432-025-06277-9.
2
Genomic and clinical insights into ovarian cancer: subtype-specific alterations and predictors of metastasis and relapse.卵巢癌的基因组与临床见解:亚型特异性改变以及转移和复发的预测因素
Discov Oncol. 2025 May 24;16(1):907. doi: 10.1007/s12672-025-02725-7.
3

本文引用的文献

1
Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.丹麦一项针对生育年龄妇女的前瞻性全国队列研究:当代激素避孕与卵巢癌的关联。
BMJ. 2018 Sep 26;362:k3609. doi: 10.1136/bmj.k3609.
2
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
3
Regulation of PEST-containing nuclear proteins in cancer cells: implications for cancer biology and therapy.
癌细胞中含PEST核蛋白的调控:对癌症生物学和治疗的意义。
Front Oncol. 2025 Apr 22;15:1548886. doi: 10.3389/fonc.2025.1548886. eCollection 2025.
4
Effects of anesthetics on development of gynecological cancer.麻醉剂对妇科癌症发展的影响。
Front Cell Dev Biol. 2025 Apr 16;13:1587548. doi: 10.3389/fcell.2025.1587548. eCollection 2025.
5
Trends in national and ethnic burden of ovarian cancer mortality in South Africa (1999-2018): a population based, age-period-cohort and join point regression analyses.南非卵巢癌死亡率的国家和种族负担趋势(1999 - 2018年):基于人群的年龄-时期-队列及连接点回归分析
BMC Cancer. 2025 Mar 20;25(1):515. doi: 10.1186/s12885-025-13735-7.
6
Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.按组织学亚型划分的全球卵巢癌发病率模式与趋势:一项基于人群的1988年至2017年分析。
EClinicalMedicine. 2024 Dec 6;79:102983. doi: 10.1016/j.eclinm.2024.102983. eCollection 2025 Jan.
7
Reproductive factors and risk of epithelial ovarian cancer: results from the Asia Cohort Consortium.生殖因素与上皮性卵巢癌风险:亚洲队列联盟的研究结果
Br J Cancer. 2025 Mar;132(4):361-370. doi: 10.1038/s41416-024-02924-z. Epub 2024 Dec 20.
8
Trends in incidence and mortality for gynaecological cancers in Southeastern China during 2011-2020: a retrospective analysis of registry data.2011-2020 年中国东南部妇科癌症发病和死亡趋势:基于登记数据的回顾性分析。
BMJ Open. 2024 Sep 28;14(9):e083336. doi: 10.1136/bmjopen-2023-083336.
9
Time trend analysis of rare cancer incidence 2011-2018: Nationwide population-based cancer registries in Japan.2011-2018 年罕见癌症发病率的时间趋势分析:日本全国基于人群的癌症登记处。
Cancer Sci. 2024 Jul;115(7):2417-2443. doi: 10.1111/cas.16176. Epub 2024 Apr 13.
10
Global epidemiology of epithelial ovarian cancer.上皮性卵巢癌的全球流行病学。
Nat Rev Clin Oncol. 2024 May;21(5):389-400. doi: 10.1038/s41571-024-00881-3. Epub 2024 Mar 28.
Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.卵巢癌的预防、筛查和早期检测:第 11 届两年一度卵巢癌研究研讨会报告。
Int J Gynecol Cancer. 2017 Nov;27(9S Suppl 5):S20-S22. doi: 10.1097/IGC.0000000000001118.
4
Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.卵巢癌流行病学的当前差距:开展新的基于人群研究的必要性。
J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx144.
5
Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?卵巢癌的起源细胞:卵巢表面上皮还是输卵管?
Arch Gynecol Obstet. 2017 Dec;296(6):1055-1062. doi: 10.1007/s00404-017-4529-z. Epub 2017 Sep 23.
6
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.卵巢癌发病率的国际模式与趋势,总体及按组织学亚型划分的情况。
Int J Cancer. 2017 Jun 1;140(11):2451-2460. doi: 10.1002/ijc.30676. Epub 2017 Mar 21.
7
Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future.美国白人和澳大利亚女性激素使用情况及卵巢癌发病率趋势:对未来的启示。
Cancer Causes Control. 2017 May;28(5):365-370. doi: 10.1007/s10552-017-0868-0. Epub 2017 Feb 23.
8
The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses.子宫内膜异位症、输卵管结扎、子宫切除术与上皮性卵巢癌之间的关联:荟萃分析
Int J Environ Res Public Health. 2016 Nov 14;13(11):1138. doi: 10.3390/ijerph13111138.
9
Trends in the use of oral contraceptives among adolescents and young women in Spain.西班牙青少年及年轻女性口服避孕药的使用趋势。
Reprod Health. 2016 Sep 23;13(1):122. doi: 10.1186/s12978-016-0239-4.
10
Global trends and predictions in ovarian cancer mortality.全球卵巢癌死亡率的趋势和预测。
Ann Oncol. 2016 Nov;27(11):2017-2025. doi: 10.1093/annonc/mdw306. Epub 2016 Sep 5.